THE DEFINITIVE GUIDE TO OXYCODONE NORGE

Exhibits incomplete cross-tolerance, unpredictable bioavailability, substantial interpatient variability, and an elimination 50 percent-daily life that greatly exceeds its analgesic efficacy, all which makes it a challenge to initiate and titrate and resulting in greatest fee of Loss of life secondary to respiratory despair among the prescribed opi